Thursday, June 30, 2022 4:25:10 PM
It's to keep the hopes alive of the retail community about the potential for an MDT buyout (which already happened when MDT got the IP they wanted). Note that Vance was at Covidien over 12 years ago - that's a long time - and by the time MDT merged with Covidien, Vance was long gone. So in reality, Vance had no overlap with MDT at all. The parenthetical is arguably disingenuous to link him to MDT.
Separately, they run a 6-9 month CEO search and all they come up with is an existing board member to fill the role who hasn't been an active CEO for years - i.e., he was dragged out from retirement. That tells you no one else wanted to do it - the question is, why? Was it because they didn't want to take a sure thing MDT buyout payday or be a part of the imminent launch of a transformative medical device? Huh, I wonder what they saw that many here don't ...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM